HK1042706A1 - 低腺苷反義寡核苷酸製劑、組合物、試劑盒及處理 - Google Patents

低腺苷反義寡核苷酸製劑、組合物、試劑盒及處理

Info

Publication number
HK1042706A1
HK1042706A1 HK02102614.0A HK02102614A HK1042706A1 HK 1042706 A1 HK1042706 A1 HK 1042706A1 HK 02102614 A HK02102614 A HK 02102614A HK 1042706 A1 HK1042706 A1 HK 1042706A1
Authority
HK
Hong Kong
Prior art keywords
treatments
kit
composition
sense oligonucleotide
oligonucleotide agent
Prior art date
Application number
HK02102614.0A
Other languages
English (en)
Inventor
喬納森‧W‧尼斯
Original Assignee
東卡羅來納大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東卡羅來納大學 filed Critical 東卡羅來納大學
Publication of HK1042706A1 publication Critical patent/HK1042706A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/334—Modified C
HK02102614.0A 1998-08-03 2002-04-08 低腺苷反義寡核苷酸製劑、組合物、試劑盒及處理 HK1042706A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9521298P 1998-08-03 1998-08-03
PCT/US1999/017712 WO2000009525A2 (en) 1998-08-03 1999-08-03 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments

Publications (1)

Publication Number Publication Date
HK1042706A1 true HK1042706A1 (zh) 2002-08-23

Family

ID=22250687

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102614.0A HK1042706A1 (zh) 1998-08-03 2002-04-08 低腺苷反義寡核苷酸製劑、組合物、試劑盒及處理

Country Status (6)

Country Link
EP (1) EP1102786A4 (zh)
CN (1) CN1317009A (zh)
AU (1) AU5337499A (zh)
CA (1) CA2333901A1 (zh)
HK (1) HK1042706A1 (zh)
WO (1) WO2000009525A2 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825174B2 (en) 1995-06-07 2004-11-30 East Carolina University Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
US7034007B1 (en) 1995-06-07 2006-04-25 East Carolina University Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depletion
WO2000058468A2 (en) * 1999-03-26 2000-10-05 Human Genome Sciences, Inc. 47 human secreted proteins
JP2002539811A (ja) * 1999-03-26 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４８個のヒト分泌タンパク質
BR0006019A (pt) * 1999-04-06 2001-03-13 Univ East Carolina Oligonucleotìdeo de anti-sentido de adenosina baixo, composições, kit & método para tratamento de distúrbios de vias aéreas associados com broncoconstricção, inflamação pulmonar, alergia(s) & depleção de surfactante
US6489151B1 (en) * 2000-03-27 2002-12-03 The Research Foundation Of State University Of New York Biologically active alternative form of the IKKα IκB kinase
DE10019252A1 (de) * 2000-04-18 2001-10-31 Klaus Karl Degitz Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression
DE10049549A1 (de) * 2000-10-06 2002-05-02 Markus Hecker Modulation der Transkription pro-inflammatorischer Genprodukte
DK1406667T3 (da) * 2001-07-06 2008-06-16 Topigen Pharmaceuticals Inc Fremgangsmåder til at öge oligonukleotiders in vivo-effektivitet og hæmme inflammation hos pattedyr
EP1492885A2 (en) * 2002-04-05 2005-01-05 University Court of the University of Edinburgh Schizophrenia associated genes
AR040996A1 (es) 2002-08-19 2005-04-27 Coley Pharm Group Inc Acidos nucleicos inmunoestimuladores
CN1322899C (zh) * 2004-02-11 2007-06-27 中国科学院上海生命科学研究院 抗肝癌基因药物组合物、小分子干扰rna及其筛选方法
ES2450929T3 (es) 2004-10-29 2014-03-25 Topigen Pharmaceuticals Inc. Oligonucleótidos antisentido para tratar la alergia y la proliferación de las células neoplásicas
EP1926747A1 (en) 2005-08-12 2008-06-04 Schering Corporation Mcp1 fusions
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
US10017762B2 (en) * 2010-11-24 2018-07-10 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for treating or preventing lupus
RU2584573C2 (ru) * 2011-06-15 2016-05-20 Грайфолз Терепьютикс Инк. Способы, композиции и наборы для определения вируса иммунодефицита человека (вич)
CN102866153B (zh) * 2012-09-29 2014-08-13 郑州安图生物工程股份有限公司 前列腺炎联合检测试剂盒
JP2016513968A (ja) * 2013-03-11 2016-05-19 ユニバーシティー オブ ノースキャロライナ アット チャペル ヒルＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ Ｏ−結合ｎ−アセチルグルコサミントランスフェラーゼを標的する組成物及び方法並びに創傷治癒を促進する組成物及び方法
EP4237436A2 (en) * 2020-10-29 2023-09-06 Mariano A. Garcia-Blanco Soluble interleukin-7 receptor (sil7r) modulating therapy to treat cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE637965T1 (de) * 1991-11-26 1995-12-14 Gilead Sciences Inc Gesteigerte bildung von triple- und doppelhelices aus oligomeren mit modifizierten pyrimidinen.
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US6498147B2 (en) * 1992-05-22 2002-12-24 The Scripps Research Institute Suppression of nuclear factor-κb dependent processes using oligonucleotides
US5994315A (en) * 1995-06-07 1999-11-30 East Carolina University Low adenosine agent, composition, kit and method for treatment of airway disease
US5856462A (en) * 1996-09-10 1999-01-05 Hybridon Incorporated Oligonucleotides having modified CpG dinucleosides
US5932557A (en) * 1997-08-12 1999-08-03 Mustafa; S. Jamal Adenosine A1 receptor antisense oligonucleotide treatment of alcohol and marijuana-induced psychomotor impairments
EP1080225A4 (en) * 1998-05-21 2004-02-04 Isis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR THE PULMONAL ADMINISTRATION OF NUCLEIC ACIDS

Also Published As

Publication number Publication date
EP1102786A2 (en) 2001-05-30
EP1102786A4 (en) 2002-03-06
WO2000009525A3 (en) 2000-05-18
CA2333901A1 (en) 2000-02-24
AU5337499A (en) 2000-03-06
CN1317009A (zh) 2001-10-10
WO2000009525A2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
EP1102786A4 (en) AGENT COMPRISING ANTISENSE OLIGONUCLEOTIDES WITH LOW ADENOSINE CONTENT, COMPOSITION, KIT AND TREATMENTS
AP2000002015A0 (en) Pyrrolo¬2,3d¾pyrimidine compositions and their use
ZA994141B (en) Conditioning detergent composition and use.
HUP0003364A3 (en) Quinoline-indole antimicrobial agents, uses and compositions related thereto
IL143379A0 (en) ANTISENSE OLIGONUCLEOTIDE AGAINST HUMAN AChE AND USES THEREOF
IL189430A0 (en) 13-membered azalides and their use as antibiotic agents
GB9813271D0 (en) Composition and use
HK1034722A1 (en) Antipicornaviral compounds, their preparation and use
AU7124398A (en) Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
HUP0103845A2 (hu) Fertőtlenítő készítmény és alkalmazása
GB9817235D0 (en) Compound,composition and use
GB2324727B (en) Antimicrobial compositions, their preparation and use
HK1031725A1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
HUP0102808A3 (en) Ectoparasiticide agents
GB0026467D0 (en) Compound, composition and use
GB9903447D0 (en) Compound, composition and use
HUP0104350A3 (en) Synergetic fungicidal composition comprising thieno[2,3-d]pyrimidin-4-one and its use
ZA200006020B (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
AU6459199A (en) Antisense oligonucleotides which inhibit telomerase's activity and their uses
AU2001240098A1 (en) 4'-thio-l-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof
GB0100361D0 (en) Compound, composition and use
GB9917593D0 (en) Compound, composition, process and use
GB9820631D0 (en) Hair treatment composition, method and use
GB0005301D0 (en) Compound, composition and use
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use